DuPage Medical Group has closed the formation of a strategic partnership with funds managed by the private equity group Ares Management. The investment by Ares will enable continued support for growth initiatives across the entire organisation, including DMG’s practice management company, DMG Practice Management Solutions, and DMG’s subsidiary, Boncura Health
Deutsche Asset Management (Deutsche AM) has provided a EUR45 million mezzanine facility to Ares Management on two designer outlet centres located in the French cities of Troyes and Roubaix. Andrea Vanni, Head of European Real Estate Debt Investments for Deutsche AM, says: “We are excited to be a part of
NorthEdge Capital has invested in Bridge Farm Nurseries (Bridge Farm), a producer of ornamental plants, flowers and herbs in the UK, backing a management buyout from its family shareholders. It is the first deal for the firm’s recently opened Midlands office. Founded in 1988 and headquartered in Spalding in Lincolnshire,
Options, a provider of cloud-enabled managed services to the global capital markets, has secured a significant investment from Bregal Sagemount, a New York-based private equity firm focused on growth-oriented investments. The transaction, which sees Bregal Sagemount invest nearly USD100 million in Options, will enable the firm’s executive team to pursue
Private equity deal volumes and valuations are beginning to diverge with the pace of PE investment activity slowing year over year while valuations have climbed to a 10-year high, according to Murray Devine’s inaugural H1 Private Equity Valuations Report. The report, which analyses data provide by PitchBook to examine trends
Private equity firm Calculus Capital, a leading EIS and VCT investor, has completed its third deal in two weeks, investing GBP2.5m in Cambridge-based Axol Bioscience (Axol), a provider of stem cells produced from reprogrammed human blood and tissue cells. Axol supplies high quality human cells – especially live human neurons
An affiliate of HIG Capital (HIG), a global private equity investment firm with USD22 billion of equity capital under management, has acquired NCI, a diversified IT and professional services company that provides software development, information assurance, IT system engineering and modernisation and other enterprise IT solutions primarily to the US
NGX Bio has closed a USD3 million funding round led by 180 Degree Capital Corp with participation from Third Kind Venture Capital, Lateral Capital, the Band of Angels and the Berkeley Angel Network, as well as other investors. NGX Bio was founded in 2014 to provide streamlined, on-line access to
SnapApp, provider of an SaaS platform used by B2B marketers to create, publish, and measure interactive content, has closed USD10.2 million in additional funding from its principal investor, Providence Strategic Growth, the growth equity affiliate of Providence Equity Partners. The Series B round follows a period of sustained and rapid
VentureMed Group (VMG), a medical device company developing and commercialising next-generation endovascular products to treat patients suffering from peripheral artery disease (PAD), has raised USD15 million in new equity financing. The Series B Round was led by new investor Endeavour Vision, a technology and life science investor based in Geneva,
12 November, 2026 – 5:00 pm
12 November, 2026 – 8:00 am
12 February, 2026 – 8:00 am
12 February, 2026 – 5:00 pm
